ATRA vs IR · rev $128.9M vs P/E 49, rev $7.24B
Atara Biotherapeutics Inc (ATRA) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
ATRA currently screens at market cap $87.1M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the ATRA and IR stock pages for the full models.
Not investment advice.